Cefoxitin Injection, Powder, For Solution
Product Images NDC 0143-9878

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Cefoxitin (NDC 0143-9878). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Chemical Structure (Cefoxitin For Injection 1)

Chemical Structure (Cefoxitin For Injection 1)
FDA Label Image

Ndc 0143-9878-01 Cefoxitin For Injection, Usp 1 G*/vial For Iv Use Only Rx Only * Each Vial Contains Cefoxitin Sodium Equivalent To 1 G Cefoxitin. The Sodium Content Is 53.8 mg (2.3 Meq). For The Preparation Of Iv Solutions And The Usual Adult Dosage: See Package Insert. After Initial Constitution, The Solution Maintains Satisfactory Potency For 6 Hours At Room Temperature Or For 1 Week Under Refrigeration (below 5ºc (41ºf)). Store Dry Material Between 2º To 25ºc (36º To 77ºf). Avoid Exposure To Temperatures Above 50ºc (122ºf). Color Changes In Powder Or Solution Do Not Affect Potency. Date/time _________________ / _________________ (Cefoxitin For Injection 2)

Ndc 0143-9878-01 Cefoxitin For Injection, Usp 1 G*/vial For Iv Use Only Rx Only * Each Vial Contains Cefoxitin Sodium Equivalent To 1 G Cefoxitin. The Sodium Content Is 53.8 mg (2.3 Meq). For The Preparation Of Iv Solutions And The Usual Adult Dosage: See Package Insert. After Initial Constitution, The Solution Maintains Satisfactory Potency For 6 Hours At Room Temperature Or For 1 Week Under Refrigeration (below 5ºc (41ºf)). Store Dry Material Between 2º To 25ºc (36º To 77ºf). Avoid Exposure To Temperatures Above 50ºc (122ºf). Color Changes In Powder Or Solution Do Not Affect Potency. Date/time _________________ / _________________ (Cefoxitin For Injection 2)
FDA Label Image

25 X 1 G* Vials Ndc 0143-9878-25 Cefoxitin For Injection, Usp 1 G*/vial For Iv Use Only Rx Only (Cefoxitin For Injection 3)

25 X 1 G* Vials Ndc 0143-9878-25 Cefoxitin For Injection, Usp 1 G*/vial For Iv Use Only Rx Only (Cefoxitin For Injection 3)
CEFOXITIN FOR INJECTION, USP is an intravenous medication used to treat various bacterial infections. The medication is manufactured by Hikma Farmaceutica in Portugal and distributed by West-Ward in New Jersey. Each vial contains cefoxitin sodium equivalent to 1g of cefoxitin, and the sodium content is 53.8mg (2.3mEq). The medication can be stored at room temperature or under refrigeration, and after initial constitution, the solution maintains its potency for 48 hours. The medication is sold in a package of 25 vials.*
FDA Label Image

25 X 1 G* Vials Ndc 0143-9878-25 Cefoxitin For Injection, Usp 1 G*/vial For Iv Use Only Rx Only *each Vial Contains Cefoxitin Sodium Equivalent To 1 G Cefoxitin. The Sodium Content Is 53.8 mg (2.3 Meq). For The Preparation Of I.v. Solutions And Usual Adult Dosage: See Package Insert. After Initial Constitution, The Solution Maintains Satisfactory Potency For 6 Hours At Room Temperature Or For 1 Week Under Refrigeration (below 5ºc). Store Dry Material Between 2-25ºc (36-77ºf). Avoid Exposure To Temperatures Above 50ºc. Color Changes In Powder Or Solution Do Not Affect Potency. (Cefoxitin For Injection 4)

25 X 1 G* Vials Ndc 0143-9878-25 Cefoxitin For Injection, Usp 1 G*/vial For Iv Use Only Rx Only *each Vial Contains Cefoxitin Sodium Equivalent To 1 G Cefoxitin. The Sodium Content Is 53.8 mg (2.3 Meq). For The Preparation Of I.v. Solutions And Usual Adult Dosage: See Package Insert. After Initial Constitution, The Solution Maintains Satisfactory Potency For 6 Hours At Room Temperature Or For 1 Week Under Refrigeration (below 5ºc). Store Dry Material Between 2-25ºc (36-77ºf). Avoid Exposure To Temperatures Above 50ºc. Color Changes In Powder Or Solution Do Not Affect Potency. (Cefoxitin For Injection 4)
This is a description of an injectable medication called Cefoxitin for intravenous use. The medication comes in 2g vials and each vial contains Cefoxitin sodium equivalent. The standard adult dosage is provided on the package insert. After it is constituted, the solution remains potent at room temperature for 6 hours or for 1 week if refrigerated. Storage requirements and precautions against temperature exposure are also listed. The product was made by Hrmafarmaceutica in Portugal and distributed by Westauard Pharmaceutical Company in the United States. Lot and expiration date information is also provided.*
FDA Label Image

Ndc 0143-9877-01 Cefoxitin For Injection, Usp 2 G*/vial For Iv Use Only Rx Only * Each Vial Contains Cefoxitin Sodium Equivalent To 2 G Cefoxitin. The Sodium Content Is 107.6 mg (4.6 Meq). For The Preparation Of Iv Solutions And The Usual Adult Dosage: See Package Insert. After Initial Constitution, The Solution Maintains Satisfactory Potency For 6 Hours At Room Temperature Or For 1 Week Under Refrigeration (below 5ºc (41ºf)). Store Dry Material Between 2º To 25ºc (36º To 77ºf). Avoid Exposure To Temperatures Above 50ºc (122ºf). Color Changes In Powder Or Solution Do Not Affect Potency. Date/time _________________ / _________________ (Cefoxitin For Injection 5)

Ndc 0143-9877-01 Cefoxitin For Injection, Usp 2 G*/vial For Iv Use Only Rx Only * Each Vial Contains Cefoxitin Sodium Equivalent To 2 G Cefoxitin. The Sodium Content Is 107.6 mg (4.6 Meq). For The Preparation Of Iv Solutions And The Usual Adult Dosage: See Package Insert. After Initial Constitution, The Solution Maintains Satisfactory Potency For 6 Hours At Room Temperature Or For 1 Week Under Refrigeration (below 5ºc (41ºf)). Store Dry Material Between 2º To 25ºc (36º To 77ºf). Avoid Exposure To Temperatures Above 50ºc (122ºf). Color Changes In Powder Or Solution Do Not Affect Potency. Date/time _________________ / _________________ (Cefoxitin For Injection 5)
This is a description of Cefoxitin injection, a medication used for intravenous (IV) use only. Each vial contains 2g of cefoxitin sodium and the medication is made by HIKMA FARMACEUTICA (PORTUGAL), SA. The package insert contains instructions for preparation of the IV solution and usual adult dosage. After initial preparation, the solution can be stored at room temperature for up to 8 hours or refrigerated for up to 1 week. The medication should be stored at temperatures between 2°C and 25°C (36°F and 77°F) and protected from temperatures above 50°C. Color changes in the powder or solution do not affect potency.*
FDA Label Image

25 X 2 G* Vials Ndc 0143-9877-25 Cefoxitin For Injection, Usp 2 G*/vial For Iv Use Only Rx Only (Cefoxitin For Injection 6)

25 X 2 G* Vials Ndc 0143-9877-25 Cefoxitin For Injection, Usp 2 G*/vial For Iv Use Only Rx Only (Cefoxitin For Injection 6)
This appears to be a product label or packaging with a Global Trade Item Number (GTIN), Serial Number (SN), Expiration Date (EXP), and Lot Number (LOT) for identification and tracking purposes. However, without more information on the product or company, the purpose or contents of the label cannot be determined.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.